Murad Elsadawi MD
Hematopathology, Obstetrics & Perinatal Pathology, Anatomic Pathology, Clinical Pathology
Physician
Join to View Full Profile
41 Burlington Mall RdBurlington, MA 01805
Dr. Elsadawi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Murad Elsadawi is a pathologist located in Burlington, MA, with subspecialties in hematopathology, anatomic pathology, and surgical pathology. He completed his pathology residency at Boston University Medical Center in 2022, following his medical degree from Garyounis University Faculty of Medicine in 2010. He is currently an MD at both the University of Rochester Medical Center and Boston Medical Center. His research work includes publications on topics like acute promyelocytic leukemia, paclitaxel's iatrogenic effects, lung adenocarcinoma, and uterine corpus carcinoma in reputable journals such as Genes, Vascular Medicine, Histopathology, and the International Journal of Gynecological Cancer.
Education & Training
University of Rochester Medical CenterFellowship, Hematopathology, 2022 - 2023
Boston University Medical CenterResidency, Pathology-Anatomic and Clinical, 2018 - 2022
Garyounis University Faculty of MedicineClass of 2010
Certifications & Licensure
MA State Medical License 2018 - 2027
PA State Medical License 2022 - 2024
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Utilization of RT-PCR and Optical Genome Mapping in Acute Promyelocytic Leukemia with CrypticRearrangement: A Case Discussion and Systemic Literature Review.Giby V George, Murad Elsadawi, Andrew G Evans, Sarmad Ali, Bin Zhang
Genes. 2024-12-25 - Alleviating iatrogenic effects of paclitaxel via antiinflammatory treatment.Mengwei Zhang, Saran Lotfollahzadeh, Nagla Elzinad, Xiaosheng Yang, Murad Elsadawi
Vascular Medicine. 2024-08-01 - ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.Giby V George, Danielle S Wallace, Ying Wang, John Carney, Murad Elsadawi
Histopathology. 2024-04-01
Journal Articles
- Kinetic and dynamic description of caffeineSami G Alsabri, Walid O Mari, Sara Younes, Murad A Alsadawi, Terry L Oroszi, Journal of Caffeine and Adenosine Research, 3/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
